Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT03382288Not ApplicableCompleted

Clinical Trial ES 900 - 2016

Role: lead

NCT04112472Not ApplicableCompleted

Clinical Trial ES 900 - 2019

Role: lead

NCT04392349Not ApplicableCompleted

Clinical Study - ES 900 - 2020-2

Role: lead

NCT07007897Enrolling By Invitation

Observational Study - TA- 2025-1

Role: lead

NCT05819307Unknown

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)

Role: collaborator

NCT05304182Not ApplicableUnknown

Clinical Study - ES 900 - 2020-1

Role: lead

NCT01861925Completed

Study of Clinical Performance of Corneal Topography Measurement Using an Optical Biometer

Role: lead

NCT01518686Not ApplicableCompleted

Age-related Normative Values for the Octopus 900 Perimeter

Role: collaborator

NCT01265628Completed

Validation of the GATE Software

Role: collaborator

NCT00555763Phase 3Completed

Assessment of a New Goldmann Applanation Tonometer

Role: collaborator

NCT00494390Completed

Evaluation Study for a Non-Contact Biometer

Role: collaborator

All 11 trials loaded